Vista

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• High blood pressure2 trials
• Obesity1 trial
• Type 1 diabetes1 trial
• Type 2 diabetes1 trial

Phase

• Phase 1/21 trial
• Phase 21 trial
• Phase 31 trial

Status

• Completed1 trial
• Recruiting1 trial
• Terminated1 trial

Lead sponsor

• Alnylam Pharmaceuticals3 trials

Running trials

• Recruiting

  Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

  NCT07181109· Phase 3· Alnylam Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• High blood pressure1 recruiting

Closed trials

• Terminated

  A Phase 1/2 Study to Evaluate ALN-KHK in Overweight to Obese Healthy Volunteers and Obese Patients With T2DM

  NCT05761301· Phase 1/2· Alnylam Pharmaceuticals· Source

• Completed

  A Study to Evaluate Efficacy and Safety of ALN-AGT01 in Patients With Mild To-Moderate Hypertension

  NCT04936035· Phase 2· Alnylam Pharmaceuticals· Source